Assembly drives regioselective azide-alkyne cycloaddition reaction

Q Jiang, W Zhan, X Liu, L Bai, M Wang, Y Xu… - Nature …, 2023 - nature.com
Azide-alkyne cycloaddition reaction is a very common organic reaction to synthesize
nitrogen-containing heterocycles. Once catalyzed by Cu (I) or Ru (II), it turns out to be a click …

Recent Advances in Pyrimidine-Based Drugs

B Nammalwar, RA Bunce - Pharmaceuticals, 2024 - mdpi.com
Pyrimidines have become an increasingly important core structure in many drug molecules
over the past 60 years. This article surveys recent areas in which pyrimidines have had a …

New trends in diagnosing and treating ovarian cancer using nanotechnology

J Zhang, H Ding, F Zhang, Y Xu, W Liang… - … in Bioengineering and …, 2023 - frontiersin.org
Ovarian cancer stands as the fifth most prevalent cancer among women, causing more
mortalities than any other disease of the female reproductive system. There are numerous …

Sustained Release of Neuroprotective Drugs Curcumin and Edaravone from Supramolecular Hydrogel for Ischemic Stroke Treatment

Y Jia, Y Zhang, W Zhan, Y Wang, X Sun… - Advanced Functional …, 2023 - Wiley Online Library
Ischemic stroke is a major cause of death and disability worldwide. The poor drug delivery to
cerebral ischemic regions remains a challenging issue for ischemic stroke treatment …

Aurora Kinase B‐Instruct Release of AZD1152‐HQPA from Hydrogel to Enhance Cervical Cancer Suppression

G Xu, Q Weng, L Zhang, Y Song… - Advanced Functional …, 2024 - Wiley Online Library
Aurora kinase B (AURKB) is an attractive and potential molecular target for cervical cancer
therapy. To date, a variety of AURKB inhibitors are developed to suppress cervical tumors …

Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter

S Feng, B Ding, Z Dai, H Yin, Y Ding, S Liu… - Journal of Translational …, 2024 - Springer
Background Ovarian cancer (OC) is distinguished by its aggressive nature and the limited
efficacy of current treatment strategies. Recent studies have emphasized the significant role …

Roles of salt‑inducible kinases in cancer

S Feng, F Wei, H Shi, S Chen… - International …, 2023 - spandidos-publications.com
Salt inducible kinases (SIKs) with three subtypes SIK1, SIK2 and SIK3, belong to the AMP‑
activated protein kinase family. They are expressed ubiquitously in humans. Under normal …

[HTML][HTML] Weak acid-initiated slow release of Dexamethasone from hydrogel to treat orbital inflammation

J Li, A Zhang, A Zhao, Z Chen, G Liang, H Liu, C Wu - Theranostics, 2023 - ncbi.nlm.nih.gov
Rationale: Orbital inflammation is a prevalent and prolonged ocular disease that poses a
significant challenge to clinicians. Glucocorticoid Dexamethasone sodium phosphate (Dex) …

Recent research progress on tumour-specific responsive hydrogels

XY Zhou, CK Wang, ZF Shen, YF Wang… - Journal of Materials …, 2024 - pubs.rsc.org
Most existing hydrogels, even recently developed injectable hydrogels that undergo a
reversible sol‒gel phase transition in response to external stimuli, are designed to gel …

Discovery of pyrimidine-5-carboxamide derivatives as novel salt-inducible kinases (SIKs) inhibitors for inflammatory bowel disease (IBD) treatment

X Cai, L Wang, Y Yi, D Deng, M Shi, M Tang… - European Journal of …, 2023 - Elsevier
Salt-inducible kinases (SIKs) play a crucial role in inflammation process, acting as molecular
switches that regulate the transformation of M1/M2 macrophages. HG-9-91–01 is a SIKs …